Literature DB >> 21940401

Acute and chronic effects of SGLT2 blockade on glomerular and tubular function in the early diabetic rat.

Scott C Thomson1, Timo Rieg, Cynthia Miracle, Hadi Mansoury, Jean Whaley, Volker Vallon, Prabhleen Singh.   

Abstract

Tubuloglomerular feedback (TGF) stabilizes nephron function from minute to minute and adapts to different steady-state inputs to maintain this capability. Such adaptation inherently renders TGF less efficient at buffering long-term disturbances, but the magnitude of loss is unknown. We undertook the present study to measure the compromise between TGF and TGF adaptation in transition from acute to chronic decline in proximal reabsorption (Jprox). As a tool, we blocked proximal tubule sodium-glucose cotransport with the SGLT2 blocker dapagliflozin in hyperglycemic rats with early streptozotocin diabetes, a condition in which a large fraction of proximal fluid reabsorption owes to SGLT2. Dapagliflozin acutely reduced proximal reabsorption leading to a 70% increase in early distal chloride, a saturated TGF response, and a major reduction in single nephron glomerular filtration rate (SNGFR). Acute and chronic effects on Jprox were indistinguishable. Adaptations to 10-12 days of dapagiflozin included increased reabsorption by Henle's loop, which caused a partial relaxation in the increased tone exerted by TGF that could be explained without desensitization of TGF. In summary, TGF contributes to long-term fluid and salt balance by mediating a persistent decline in SNGFR as the kidney adapts to a sustained decrease in Jprox.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21940401      PMCID: PMC3349378          DOI: 10.1152/ajpregu.00357.2011

Source DB:  PubMed          Journal:  Am J Physiol Regul Integr Comp Physiol        ISSN: 0363-6119            Impact factor:   3.619


  25 in total

1.  THE EXCRETION OF INULIN, XYLOSE AND UREA BY NORMAL AND PHLORIZINIZED MAN.

Authors:  J A Shannon; H W Smith
Journal:  J Clin Invest       Date:  1935-07       Impact factor: 14.808

2.  Combined effects of carbonic anhydrase inhibitor and adenosine A1 receptor antagonist on hemodynamic and tubular function in the kidney.

Authors:  Cynthia M Miracle; Timo Rieg; Roland C Blantz; Volker Vallon; Scott C Thomson
Journal:  Kidney Blood Press Res       Date:  2007-09-20       Impact factor: 2.687

3.  SGLT2 mediates glucose reabsorption in the early proximal tubule.

Authors:  Volker Vallon; Kenneth A Platt; Robyn Cunard; Jana Schroth; Jean Whaley; Scott C Thomson; Hermann Koepsell; Timo Rieg
Journal:  J Am Soc Nephrol       Date:  2010-07-08       Impact factor: 10.121

4.  Hemodynamics of early tubuloglomerular feedback resetting during reduced proximal reabsorption.

Authors:  Aihua Deng; John S Hammes; Scott C Thomson
Journal:  Kidney Int       Date:  2002-12       Impact factor: 10.612

5.  Mediation of tubuloglomerular feedback by adenosine: evidence from mice lacking adenosine 1 receptors.

Authors:  D Sun; L C Samuelson; T Yang; Y Huang; A Paliege; T Saunders; J Briggs; J Schnermann
Journal:  Proc Natl Acad Sci U S A       Date:  2001-08-14       Impact factor: 11.205

6.  Glomerulotubular balance, dietary protein, and the renal response to glycine in diabetic rats.

Authors:  Larry A Slomowitz; Aihua Deng; John S Hammes; Francis Gabbai; Scott C Thomson
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2002-04       Impact factor: 3.619

Review 7.  Kidney function in early diabetes: the tubular hypothesis of glomerular filtration.

Authors:  Scott C Thomson; Volker Vallon; Roland C Blantz
Journal:  Am J Physiol Renal Physiol       Date:  2004-01

Review 8.  Renal homeostasis and tubuloglomerular feedback.

Authors:  Prabhleen Singh; Scott C Thomson
Journal:  Curr Opin Nephrol Hypertens       Date:  2010-01       Impact factor: 2.894

Review 9.  Acute renal failure: definitions, diagnosis, pathogenesis, and therapy.

Authors:  Robert W Schrier; Wei Wang; Brian Poole; Amit Mitra
Journal:  J Clin Invest       Date:  2004-07       Impact factor: 14.808

10.  Effect of carbonic anhydrase inhibition on GFR and renal hemodynamics in adenosine-1 receptor-deficient mice.

Authors:  Seiji Hashimoto; Yuning G Huang; Hayo Castrop; Pernille B Hansen; Diane Mizel; Josie Briggs; Jurgen Schnermann
Journal:  Pflugers Arch       Date:  2004-08-11       Impact factor: 3.657

View more
  112 in total

Review 1.  Efficacy and safety of SGLT2 inhibitors in the treatment of type 2 diabetes mellitus.

Authors:  Muhammad A Abdul-Ghani; Luke Norton; Ralph A DeFronzo
Journal:  Curr Diab Rep       Date:  2012-06       Impact factor: 4.810

Review 2.  Pathophysiology of diabetic kidney disease: impact of SGLT2 inhibitors.

Authors:  Ralph A DeFronzo; W Brian Reeves; Alaa S Awad
Journal:  Nat Rev Nephrol       Date:  2021-02-05       Impact factor: 28.314

3.  Primary proximal tubule hyperreabsorption and impaired tubular transport counterregulation determine glomerular hyperfiltration in diabetes: a modeling analysis.

Authors:  K Melissa Hallow; Yeshitila Gebremichael; Gabriel Helmlinger; Volker Vallon
Journal:  Am J Physiol Renal Physiol       Date:  2017-02-01

4.  SGLT2 Protein Expression Is Increased in Human Diabetic Nephropathy: SGLT2 PROTEIN INHIBITION DECREASES RENAL LIPID ACCUMULATION, INFLAMMATION, AND THE DEVELOPMENT OF NEPHROPATHY IN DIABETIC MICE.

Authors:  Xiaoxin X Wang; Jonathan Levi; Yuhuan Luo; Komuraiah Myakala; Michal Herman-Edelstein; Liru Qiu; Dong Wang; Yingqiong Peng; Almut Grenz; Scott Lucia; Evgenia Dobrinskikh; Vivette D D'Agati; Hermann Koepsell; Jeffrey B Kopp; Avi Z Rosenberg; Moshe Levi
Journal:  J Biol Chem       Date:  2017-02-14       Impact factor: 5.157

Review 5.  Renal Effects of Incretin-Based Diabetes Therapies: Pre-clinical Predictions and Clinical Trial Outcomes.

Authors:  Scott C Thomson; Volker Vallon
Journal:  Curr Diab Rep       Date:  2018-04-13       Impact factor: 4.810

6.  Effects of a new SGLT2 inhibitor, luseogliflozin, on diabetic nephropathy in T2DN rats.

Authors:  Naoki Kojima; Jan M Williams; Teisuke Takahashi; Noriyuki Miyata; Richard J Roman
Journal:  J Pharmacol Exp Ther       Date:  2013-03-14       Impact factor: 4.030

7.  Safety profile of dapagliflozin for type 2 diabetes: pooled analysis of clinical studies for overall safety and rare events.

Authors:  Agata Ptaszynska; Kristina M Johnsson; Shamik J Parikh; Tjerk W A de Bruin; Anne Marie Apanovitch; James F List
Journal:  Drug Saf       Date:  2014-10       Impact factor: 5.606

Review 8.  Sodium glucose cotransporter 2 inhibition in the diabetic kidney: an update.

Authors:  Aleksandra Novikov; Volker Vallon
Journal:  Curr Opin Nephrol Hypertens       Date:  2016-01       Impact factor: 2.894

9.  Knockout of Na-glucose transporter SGLT2 attenuates hyperglycemia and glomerular hyperfiltration but not kidney growth or injury in diabetes mellitus.

Authors:  Volker Vallon; Michael Rose; Maria Gerasimova; Joseph Satriano; Kenneth A Platt; Hermann Koepsell; Robyn Cunard; Kumar Sharma; Scott C Thomson; Timo Rieg
Journal:  Am J Physiol Renal Physiol       Date:  2012-11-14

10.  Effects of the SGLT2 inhibitor ipragliflozin on various diabetic symptoms and progression of overt nephropathy in type 2 diabetic mice.

Authors:  Atsuo Tahara; Toshiyuki Takasu
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2018-01-26       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.